Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-08-000552
Filing Date
2008-06-17
Accepted
2008-06-17 19:26:16
Documents
1
Period of Report
2008-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4953
  Complete submission text file 0000914190-08-000552.txt   6932
Mailing Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080 6505886404
Hana Biosciences Inc (Issuer) CIK: 0001140028 (see all company filings)

EIN.: 841588441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address 8585507577
MAIER PAUL V (Reporting) CIK: 0001182615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32626 | Film No.: 08904337